A higher standard is still a claim until someone shows the number. Whoever’s selling it, the question doesn’t change. Who checked, and can you see it?
Proof Not Promises.
Last week HHS said it won’t go after compounding pharmacies making 6 peptides. Today the first prescription peptide program went live: BPC-157, TB-500 and MOTS-c, filled by licensed pharmacies.
The launch lists “batch-level third-party testing” as a quality standard. It doesn’t name the lab, give a purity figure, or say whether patients will ever see the result.
Update. The policy posts to the Federal Register tomorrow. The testing standard is long: identity, assay, impurities, endotoxin, metals, two independent methods, ICH Q7 reference standards. The certificate is signed by the manufacturer’s own quality unit. No outside check needed.
Today HHS told compounding pharmacies it will not take enforcement action against them for making six peptides: BPC-157, KPV, MOTS-c, TB-500, epitalon and semax. The condition, as reported, is that the pharmacy certifies identity and purity.
A certificate is a claim. A measurement is a fact. The gap between them is the only thing I publish. Whatever the compounding rule becomes, somebody still has to check the number. Proof Not Promises.
Twelve graded A under our published method. Two graded F. Half the certificates matched what the lab measured. The other half either overstated it or were written for a different batch than the vial I bought, so they could not be checked at all.
Before you check the purity on a certificate, check the lot number.
Does the lot on the paper match the lot on the vial?
If they don’t match, that certificate isn’t describing what you’re holding.
Read the independent reports → https://t.co/YIu4ZmaNw9